poisar

Stocks · News reference

NeuroSense Intends To Proceed With Filing Of NDS To Health Canada For PrimeC For Treatment Of Amyotrophic Lateral Sclerosis, Following Constructive Pre-NDS Meeting

Jul 22, 2026, 12:38 PMBenzinga Newsdesk

The planned submission follows alignment with Health Canada on the NDS pathway and is supported by additional PARADIGM data, including a survival benefit and consistent effects across PrimeC's multi-pathway

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

NRSN
Source
benzinga
Observed
Jul 22, 2026, 12:38 PM
Checked
Jul 22, 2026, 12:38 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading